Single Giant Liver Hemangioma. Case Series With Follow-Up of Patients Treated Surgically

Tweet about this on TwitterShare on FacebookEmail this to someoneShare on Google+

Carlos Manterola; Nataniel Claros & Luis Grande


Treatment of giant hepatic hemangioma (GHH) remains controversial. The aim of this study was to report the outcomes of surgically resected GHH patients in terms of postoperative morbidity (POM). Case series with follow-up. Patients with GHH who underwent surgery consecutively at the RedSalud Mayor Clinic between 2011 and 2020 were included. The outcome variable was POM. Other variables of interest were surgical time, hospital stay and mortality. The patients were followed up clinically. Descriptive statistics were used, with measures of central tendency and dispersion. Five patients underwent surgery, with a median age of 38 years. The median surgical time and hospital stay; were 75 min and 4 days respectively. The MPO was 20 % (1 case of seroma). With a median follow-up of 41 months, the patients are asymptomatic, and no distant morbidity has been verified. Surgical resection of GHH can be performed with low morbidity, both in terms of numbers and the severity of the complication observed.

KEY WORDS: "Hemangioma"[Mesh]; "Hemangioma/ surgery"[Mesh]; "Hepatectomy"[Mesh]; hepatic hemangioma; liver hemangioma; liver Resection.

How to cite this article

MANTEROLA, C.; CLAROS, N. & GRANDE, L. Single giant liver hemangioma. Case series with follow-up of patients treated surgically. Int. J. Morphol., 40(6):1475-1480, 2022.